AIRSCULPT TECHNOLOGIES INC (AIRS)

US0094961002 - Common Stock

5.41  +0.06 (+1.12%)

After market: 5.41 0 (0%)

Fundamental Rating

3

Overall AIRS gets a fundamental rating of 3 out of 10. We evaluated AIRS against 108 industry peers in the Health Care Providers & Services industry. AIRS has a bad profitability rating. Also its financial health evaluation is rather negative. AIRS is valied quite expensively at the moment, while it does show a decent growth rate.



3

1. Profitability

1.1 Basic Checks

AIRS had negative earnings in the past year.
AIRS had a positive operating cash flow in the past year.
In multiple years AIRS reported negative net income over the last 5 years.
Each year in the past 5 years AIRS had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -3.74%, AIRS is in line with its industry, outperforming 41.12% of the companies in the same industry.
AIRS has a Return On Equity (-9.44%) which is in line with its industry peers.
AIRS has a Return On Invested Capital (1.60%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -3.74%
ROE -9.44%
ROIC 1.6%
ROA(3y)-1.41%
ROA(5y)-0.26%
ROE(3y)-4.47%
ROE(5y)-1.82%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

AIRS's Operating Margin of 1.96% is in line compared to the rest of the industry. AIRS outperforms 51.40% of its industry peers.
AIRS's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 64.98%, AIRS belongs to the top of the industry, outperforming 87.85% of the companies in the same industry.
In the last couple of years the Gross Margin of AIRS has remained more or less at the same level.
Industry RankSector Rank
OM 1.96%
PM (TTM) N/A
GM 64.98%
OM growth 3Y-33.27%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.91%
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

AIRS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for AIRS has been increased compared to 1 year ago.
The debt/assets ratio for AIRS has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 2.22 indicates that AIRS is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of AIRS (2.22) is comparable to the rest of the industry.
The Debt to FCF ratio of AIRS is 58.70, which is on the high side as it means it would take AIRS, 58.70 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of AIRS (58.70) is comparable to the rest of the industry.
AIRS has a Debt/Equity ratio of 0.80. This is a neutral value indicating AIRS is somewhat dependend on debt financing.
AIRS's Debt to Equity ratio of 0.80 is in line compared to the rest of the industry. AIRS outperforms 41.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 58.7
Altman-Z 2.22
ROIC/WACC0.19
WACC8.61%

2.3 Liquidity

AIRS has a Current Ratio of 0.51. This is a bad value and indicates that AIRS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.51, AIRS is not doing good in the industry: 90.65% of the companies in the same industry are doing better.
AIRS has a Quick Ratio of 0.51. This is a bad value and indicates that AIRS is not financially healthy enough and could expect problems in meeting its short term obligations.
AIRS has a Quick ratio of 0.51. This is amonst the worse of the industry: AIRS underperforms 87.85% of its industry peers.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.51

4

3. Growth

3.1 Past

The earnings per share for AIRS have decreased by -7.69% in the last year.
Looking at the last year, AIRS shows a decrease in Revenue. The Revenue has decreased by -0.12% in the last year.
Measured over the past years, AIRS shows a very strong growth in Revenue. The Revenue has been growing by 46.12% on average per year.
EPS 1Y (TTM)-7.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-233.33%
Revenue 1Y (TTM)-0.12%
Revenue growth 3Y46.12%
Revenue growth 5YN/A
Sales Q2Q%-9.07%

3.2 Future

The Earnings Per Share is expected to grow by 75.67% on average over the next years. This is a very strong growth
Based on estimates for the next years, AIRS will show a small growth in Revenue. The Revenue will grow by 6.69% on average per year.
EPS Next Y7.56%
EPS Next 2Y55.72%
EPS Next 3Y59.18%
EPS Next 5Y75.67%
Revenue Next Year-5.51%
Revenue Next 2Y2.09%
Revenue Next 3Y4.98%
Revenue Next 5Y6.69%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

2

4. Valuation

4.1 Price/Earnings Ratio

AIRS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 159.13, AIRS can be considered very expensive at the moment.
60.75% of the companies in the same industry are cheaper than AIRS, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.78. AIRS is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 159.13

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AIRS is on the same level as its industry peers.
AIRS's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 262.03
EV/EBITDA 24.63

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AIRS does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as AIRS's earnings are expected to grow with 59.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.72%
EPS Next 3Y59.18%

0

5. Dividend

5.1 Amount

AIRS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AIRSCULPT TECHNOLOGIES INC

NASDAQ:AIRS (12/23/2024, 4:20:00 PM)

After market: 5.41 0 (0%)

5.41

+0.06 (+1.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-08 2024-11-08/bmo
Earnings (Next)N/A N/A
Inst Owners23.03%
Inst Owner Change-0.42%
Ins Owners26.39%
Ins Owner Change-0.87%
Market Cap313.13M
Analysts74.55
Price Target7.99 (47.69%)
Short Float %15.52%
Short Ratio10.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP-2.43%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-170.97%
Min EPS beat(2)-245.86%
Max EPS beat(2)-96.08%
EPS beat(4)1
Avg EPS beat(4)-60.97%
Min EPS beat(4)-492.16%
Max EPS beat(4)590.2%
EPS beat(8)2
Avg EPS beat(8)-69.21%
EPS beat(12)3
Avg EPS beat(12)-124.83%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.78%
Min Revenue beat(2)-9.52%
Max Revenue beat(2)-0.03%
Revenue beat(4)0
Avg Revenue beat(4)-4.68%
Min Revenue beat(4)-9.52%
Max Revenue beat(4)-0.03%
Revenue beat(8)2
Avg Revenue beat(8)-1.92%
Revenue beat(12)5
Avg Revenue beat(12)-0.74%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)100%
PT rev (3m)100%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-153.76%
EPS NY rev (1m)-190%
EPS NY rev (3m)-81.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-21.98%
Revenue NY rev (1m)0.19%
Revenue NY rev (3m)0.23%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 159.13
P/S 1.66
P/FCF 262.03
P/OCF 23.19
P/B 3.79
P/tB N/A
EV/EBITDA 24.63
EPS(TTM)-0.14
EYN/A
EPS(NY)0.03
Fwd EY0.63%
FCF(TTM)0.02
FCFY0.38%
OCF(TTM)0.23
OCFY4.31%
SpS3.26
BVpS1.43
TBVpS-0.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.74%
ROE -9.44%
ROCE 2.03%
ROIC 1.6%
ROICexc 1.66%
ROICexgc 5.59%
OM 1.96%
PM (TTM) N/A
GM 64.98%
FCFM 0.63%
ROA(3y)-1.41%
ROA(5y)-0.26%
ROE(3y)-4.47%
ROE(5y)-1.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-29.15%
ROICexcg growth 5YN/A
ROICexc growth 3Y-5.14%
ROICexc growth 5YN/A
OM growth 3Y-33.27%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.91%
GM growth 5YN/A
F-Score4
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 58.7
Debt/EBITDA 4.38
Cap/Depr 107.34%
Cap/Sales 6.52%
Interest Coverage 0.62
Cash Conversion 88.98%
Profit Quality N/A
Current Ratio 0.51
Quick Ratio 0.51
Altman-Z 2.22
F-Score4
WACC8.61%
ROIC/WACC0.19
Cap/Depr(3y)121.64%
Cap/Depr(5y)103.97%
Cap/Sales(3y)6.02%
Cap/Sales(5y)6.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-233.33%
EPS Next Y7.56%
EPS Next 2Y55.72%
EPS Next 3Y59.18%
EPS Next 5Y75.67%
Revenue 1Y (TTM)-0.12%
Revenue growth 3Y46.12%
Revenue growth 5YN/A
Sales Q2Q%-9.07%
Revenue Next Year-5.51%
Revenue Next 2Y2.09%
Revenue Next 3Y4.98%
Revenue Next 5Y6.69%
EBIT growth 1Y33.42%
EBIT growth 3Y-2.49%
EBIT growth 5YN/A
EBIT Next Year111.75%
EBIT Next 3Y52.34%
EBIT Next 5Y52.22%
FCF growth 1Y217.16%
FCF growth 3Y10.98%
FCF growth 5YN/A
OCF growth 1Y11.6%
OCF growth 3Y19.72%
OCF growth 5YN/A